Trial Profile
Investigation of the Metabolism and Pharmacokinetics of 20 µg (Calculated as Free Base) [14C]BI 1744 CL Administered as a 3-hour Infusion and 40 µg (Calculated as Free Base) [14C]BI 1744 CL Administered as an Oral Solution.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2014
Price :
$35
*
At a glance
- Drugs Olodaterol (Primary) ; Olodaterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 28 Jun 2014 New trial record